GlassHC, SoulJS, ChangT, et al. Safety of early discontinuation of antiseizure medication after acute symptomatic neonatal seizures. JAMA Neurol. 2021;78(7):817–25.
GlassHC, ShellhaasRA, WusthoffCJ, ChangT, AbendNS, ChuCJ, et al. Contemporary profile of seizures in neonates: A prospective cohort study. J Pediatr. 2016;174:98–103e101.
4.
KharoshankayaL, StevensonNJ, LivingstoneV, MurrayDM, MurphyBP, AhearneCE, et al. Seizure burden and neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy. Dev Med Child Neurol. 2016;58(12):1242–8.
5.
WusthoffCJ, SundaramV, AbendNS, MasseySL, LemmonME, ThomasC, et al. Seizure control in neonates undergoing screening vs confirmatory EEG monitoring. Neurology. 2021;97(6):e587–e596.
6.
KramerK, BekmezianA, NashK, PappE, GlassHC. Expediting treatment of seizures in the intensive care nursery. Pediatrics. 2021;148(3):e2020013730.
7.
ShellhaasRA, WusthoffCJ, NumisAL, ChuCJ, MasseySL, AbendNS, et al. Early-life epilepsy after acute symptomatic neonatal seizures: A prospective multicenter study. Epilepsia. 2021;62(8):1871–82.
8.
World Health Organization Guidelines on Neonatal Seizures in WHO Guidelines Approved by the Guidelines Review Committee. 2011.
9.
ShellhaasRA, ChangT, TsuchidaT, ScherMS, RivielloJJ, AbendNS, et al. The American Clinical Neurophysiology Society’s guideline on continuous electroencephalography monitoring in neonates. J Clin Neurophysiol. 2011;28(6):611–7.
10.
LynchNE, StevensonNJ, LivingstoneV, MathiesonS, MurphyBP, RennieJM, et al. The temporal characteristics of seizures in neonatal hypoxic ischemic encephalopathy treated with hypothermia. Seizure. 2015;33:60–5.
11.
LynchNE, StevensonNJ, LivingstoneV, MurphyBP, RennieJM, BoylanGB. The temporal evolution of electrographic seizure burden in neonatal hypoxic ischemic encephalopathy. Epilepsia. 2012;53(3):549–57.
12.
GlassHC, GrinspanZM, LiY, et al. Risk for infantile spasms after acute symptomatic neonatal seizures. Epilepsia. 2020;61(12):2774–84.
13.
GlassHC, GrinspanZM, LiY, McNamaraNA, ChangT, ChuCJ, et al. Initial treatment for nonsyndromic early-life epilepsy: An unexpected consensus. Pediatr Neurol. 2017;75:73–9.
14.
GrinspanZM, KnuppKG, PatelAD, YozawitzEG, WusthoffCJ, WirrellE, et al. Comparative effectiveness of initial treatment for infantile spasms in a contemporary US cohort. Neurology. 2021;97(12):e1217–e1228.
15.
WilmshurstJM, GaillardWD, VinayanKP, TsuchidaTN, PlouinP, Van BogaertP, et al. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics. Epilepsia. 2015;56(8):1185–97.
16.
KivityS, LermanP, ArielR, DanzigerY, MimouniM, ShinnarS. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia. 2004;45(3):255–62.